Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Carcinoid Tumor × NET × Clear all

Phase

Phase 2 23 Phase 1 5 Phase 3 4 Phase 1/2 4 Phase NA 2 Phase 4 2 Phase EARLY_PHASE1 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 2 NET 1

Conditions

Neuroendocrine Tumors 16 von Hippel-Lindau Disease 1 Pheochromocytoma 1 Paraganglioma 1 Neuroblastoma 1 Multiple Endocrine Neoplasia Type 1 1 Meningioma 1 Lung Neoplasms 1 Gastro-enteropancreatic neuroendocrine tumor 1 Carcinoid Tumor 1

Interventions

gallium Ga 68 dotatate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03623984 2023-09-11

Molecular-Guided Surgery for Pancreatic and GI Neuroendocrine Cancers

University of Alabama at Birmingham

Phase EARLY_PHASE1 Withdrawn

Carcinoid Tumor, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡